Brighton Jones’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Brighton Jones's BIIB Position: Q3 2026 in Review
Brighton Jones reduced its Biogen (BIIB) stake by 11% in Q3 2026, selling an estimated $194K and leaving 7,723 shares worth $1.74M. The position accounts for 0.03% of the portfolio, ranked #346.
Brighton Jones first reported a position in BIIB in Q3 2013 and has held it in 16 quarters since. The position peaked at $1.87M in Q2 2026. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Brighton Jones held 7,723 shares of Biogen worth $1.74M as of Q3 2026.
- Brighton Jones sold 913 Biogen shares in Q3 2026, an estimated $194K.
- Biogen made up 0.03% of Brighton Jones's portfolio in Q3 2026, its #346 holding.
- Brighton Jones first reported a position in Biogen in Q3 2013 and has held it in 16 quarters since.
- Brighton Jones's Biogen position peaked at $1.87M in Q2 2026.
- 881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.